Kohl NE - Search Results

1

Interaction of mutant forms of the HIV-1 protease with substrate and inhibitors.

Darke PL, Kohl NE, Hanobik MG, Leu CT, Vacca JP, Guare JP, Heimbach JC, Dixon RA. Darke PL, et al. Among authors: kohl ne. Adv Exp Med Biol. 1991;306:483-7. doi: 10.1007/978-1-4684-6012-4_61. Adv Exp Med Biol. 1991. PMID: 1812746 No abstract available.

2

Expression of active human immunodeficiency virus type 1 protease by noninfectious chimeric virus particles.

Kohl NE, Diehl RE, Rands E, Davis LJ, Hanobik MG, Wolanski B, Dixon RA. Kohl NE, et al. J Virol. 1991 Jun;65(6):3007-14. doi: 10.1128/JVI.65.6.3007-3014.1991. J Virol. 1991. PMID: 1709693 Free PMC article.

3

Characterization of an active single polypeptide form of the human immunodeficiency virus type 1 protease.

DiIanni CL, Davis LJ, Holloway MK, Herber WK, Darke PL, Kohl NE, Dixon RA. DiIanni CL, et al. Among authors: kohl ne. J Biol Chem. 1990 Oct 5;265(28):17348-54. J Biol Chem. 1990. PMID: 2211628 Free article.

4

Active human immunodeficiency virus protease is required for viral infectivity.

Kohl NE, Emini EA, Schleif WA, Davis LJ, Heimbach JC, Dixon RA, Scolnick EM, Sigal IS. Kohl NE, et al. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4686-90. doi: 10.1073/pnas.85.13.4686. Proc Natl Acad Sci U S A. 1988. PMID: 3290901 Free PMC article.

5

cDNA cloning and expression of bovine aspartyl (asparaginyl) beta-hydroxylase.

Jia S, VanDusen WJ, Diehl RE, Kohl NE, Dixon RA, Elliston KO, Stern AM, Friedman PA. Jia S, et al. Among authors: kohl ne. J Biol Chem. 1992 Jul 15;267(20):14322-7. J Biol Chem. 1992. PMID: 1378441 Free article.

6

Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding site.

Sardana VV, Schlabach AJ, Graham P, Bush BL, Condra JH, Culberson JC, Gotlib L, Graham DJ, Kohl NE, LaFemina RL, et al. Sardana VV, et al. Among authors: kohl ne. Biochemistry. 1994 Mar 1;33(8):2004-10. doi: 10.1021/bi00174a005. Biochemistry. 1994. PMID: 8117657

7

Farnesyltransferase inhibitors: a new class of cancer chemotherapeutics.

Koblan KS, Kohl NE, Omer CA, Anthony NJ, Conner MW, deSolms SJ, Williams TM, Graham SL, Hartman GD, Oliff A, Gibbs JB. Koblan KS, et al. Among authors: kohl ne. Biochem Soc Trans. 1996 Aug;24(3):688-92. doi: 10.1042/bst0240688. Biochem Soc Trans. 1996. PMID: 8878827 Review. No abstract available.

8

Mutational analysis of conserved residues of the beta-subunit of human farnesyl:protein transferase.

Kral AM, Diehl RE, deSolms SJ, Williams TM, Kohl NE, Omer CA. Kral AM, et al. Among authors: kohl ne. J Biol Chem. 1997 Oct 24;272(43):27319-23. doi: 10.1074/jbc.272.43.27319. J Biol Chem. 1997. PMID: 9341181 Free article.

9

Development of inhibitors of protein farnesylation as potential chemotherapeutic agents.

Kohl NE, Conner MW, Gibbs JB, Graham SL, Hartman GD, Oliff A. Kohl NE, et al. J Cell Biochem Suppl. 1995;22:145-50. doi: 10.1002/jcb.240590819. J Cell Biochem Suppl. 1995. PMID: 8538192 Review.

10

Pseudopeptide inhibitors of Ras farnesyl-protein transferase.

Graham SL, deSolms SJ, Giuliani EA, Kohl NE, Mosser SD, Oliff AI, Pompliano DL, Rands E, Breslin MJ, Deana AA, et al. Graham SL, et al. Among authors: kohl ne. J Med Chem. 1994 Mar 18;37(6):725-32. doi: 10.1021/jm00032a004. J Med Chem. 1994. PMID: 8145221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters